https://assets.capyfin.com/instruments/678fdc13234e27009c5d581f.png avatar
HCA
🇺🇸 NYSE:HCA
View Company
OverviewEarningsDividends
•
Jun 30, 2021

HCA Q2 2021 Earnings Report

HCA Healthcare's financial performance rebounded in the second quarter of 2021 as the effects of the pandemic moderated. Revenues, net income, and adjusted EBITDA increased compared to the prior year. The company raised its 2021 guidance.

Key Takeaways

HCA Healthcare reported strong second quarter 2021 results, with revenues increasing to $14.435 billion and net income attributable to HCA Healthcare, Inc. totaling $1.450 billion, or $4.36 per diluted share. The company raised its 2021 guidance for revenues, adjusted EBITDA, and EPS.

Revenues totaled $14.435 billion.

Net income attributable to HCA Healthcare, Inc. totaled $1.450 billion, or $4.36 per diluted share.

Adjusted EBITDA totaled $3.219 billion.

Cash flows from operating activities totaled $2.251 billion.

Total Revenue
$14.4B
Previous year: $11.1B
+30.4%
EPS
$4.37
Previous year: $3.23
+35.3%
Admissions
532.04K
Previous year: 452.99K
+17.5%
Number of Hospitals
187
Previous year: 186
+0.5%
Licensed Beds
49.69K
Previous year: 49.4K
+0.6%
Gross Profit
$12.1B
Previous year: $9.32B
+29.3%
Cash and Equivalents
$1.12B
Previous year: $4.64B
-75.9%
Free Cash Flow
$1.41B
Previous year: $7.98B
-82.3%
Total Assets
$48.2B
Previous year: $48.7B
-1.1%

HCA

HCA

Forward Guidance

The 2021 guidance ranges for the year have been revised from our first quarter release and are as follows: Revenues $57.0 to $58.0 billion, Adjusted EBITDA $12.10 to $12.50 billion, EPS (diluted) $16.30 to $17.10 per diluted share, Capital Expenditures Approximately $3.7 billion

Company Overview

Full financial data and analysis

View HCA